Fidaxomicin as a Salvage Therapy for Fulminant Clostridioides difficile Infection

Few studies have demonstrated the efficacy of fidaxomicin in the treatment of fulminant Clostridioides difficile infection (CDI). Fidaxomicin has been used as part of the standard treatment for nonsevere and severe CDI according to the guidelines by the Infectious Diseases Society of America and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Heleno, Caio T, Tagintsev, Aleksey, Lasley, Katharine, Summerfield, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301726/
https://www.ncbi.nlm.nih.gov/pubmed/34327111
http://dx.doi.org/10.7759/cureus.16559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301726/
https://www.ncbi.nlm.nih.gov/pubmed/34327111
http://dx.doi.org/10.7759/cureus.16559

Ejemplares similares